104 related articles for article (PubMed ID: 3713694)
21. [Immunohistological studies of the skin at the injection site of cases receiving the streptococcal agent OK-432].
Hanaue H; Kurosawa T; Miyakawa S; Horie F; Nemoto A; Yamoto H; Nishimura S; Tsuchiya H; Miura S; Asagoe T
Nihon Gan Chiryo Gakkai Shi; 1985 Dec; 20(10):2271-8. PubMed ID: 3879494
[No Abstract] [Full Text] [Related]
22. [Administration of hemolytic streptococcus preparation OK-432 on recurrent gastric carcinoma].
Hanaue H; Kurosawa T; Kitano Y; Miyagawa S; Nemoto A; Yamato H; Asagoe T; Shikata J
Nihon Gan Chiryo Gakkai Shi; 1987 Aug; 22(7):1367-72. PubMed ID: 3501455
[No Abstract] [Full Text] [Related]
23. Induction of interferon-gamma and tumor necrosis factor in ascites of a patient with ovarian cancer by OK-432.
Mori H; Itoh N; Shiraki S; Tamaya T
Nihon Sanka Fujinka Gakkai Zasshi; 1988 Apr; 40(4):497-8. PubMed ID: 3131464
[No Abstract] [Full Text] [Related]
24. [Adjuvant immunochemotherapy with long-term OK-432 administration in colorectal cancer].
Kikkawa N; Sasai H; Kawahara T
Gan To Kagaku Ryoho; 1984 Oct; 11(10):2163-9. PubMed ID: 6486832
[TBL] [Abstract][Full Text] [Related]
25. [Clinical trial of oral immunotherapy with streptococcal preparation OK 432 on gastric cancer].
Nio Y; Ohgaki K; Henmi K; Kan N; Inamoto T; Tsuchitani T; Kodama H; Tobe T
Nihon Gan Chiryo Gakkai Shi; 1982 Apr; 17(3):728-34. PubMed ID: 6752308
[No Abstract] [Full Text] [Related]
26. Essential requirement of toll-like receptor 4 expression on CD11c+ cells for locoregional immunotherapy of malignant ascites using a streptococcal preparation OK-432.
Hironaka K; Yamaguchi Y; Okita R; Okawaki M; Nagamine I
Anticancer Res; 2006; 26(5B):3701-7. PubMed ID: 17094388
[TBL] [Abstract][Full Text] [Related]
27. [A study on the effectiveness of the adjuvant chemotherapy and immunotherapy and its correlation with cellular immunity].
Sachira ; Onda M; Tokunaga A
Nihon Ika Daigaku Zasshi; 1989 Jun; 56(3):308-12. PubMed ID: 2753993
[No Abstract] [Full Text] [Related]
28. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
29. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
30. [Changes of cytokine levels in ascitic fluid after intraperitoneal administration of OK-432 or CDDP].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2326-9. PubMed ID: 7944471
[TBL] [Abstract][Full Text] [Related]
31. [Influence of OK 432 upon postoperative alteration in activities producing lymphokines, IL 1, IL 2, and IFN, of peripheral blood mononuclear cells derived from patients with gastric cancer].
Hosoi J
Nihon Gan Chiryo Gakkai Shi; 1987 Apr; 22(3):603-13. PubMed ID: 2443588
[No Abstract] [Full Text] [Related]
32. The endoscopic intratumor administration of OK-432 in gastric cancer unsuitable for surgery.
Nakazawa S; Yoshino J; Kijima Y; Yasumasa N; Ohhashi S; Mizutani K
Endoscopy; 1989 Jul; 21(4):168-71. PubMed ID: 2776702
[TBL] [Abstract][Full Text] [Related]
33. [Non-specific immunotherapy with OK-432, streptococcus pyogenes preparation, for inoperable cancer patients of the digestive tract].
Hanaue H; Nomoto S; Yoshizaki S; Kitano Y; Miyakawa S; Horie F; Kurosawa T; Nemoto A; Yasuda H; Takada T
Nihon Gan Chiryo Gakkai Shi; 1984 Jul; 19(6):1307-14. PubMed ID: 6512346
[No Abstract] [Full Text] [Related]
34. [Changes in cytokine levels in ascitic fluid after intraperitoneal administration of OK-432].
Terashima M; Takagane A; Abe K; Kuboi M; Asahi H; Saito K
Gan To Kagaku Ryoho; 1993 Aug; 20(11):1443-5. PubMed ID: 8373202
[TBL] [Abstract][Full Text] [Related]
35. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. I. Experimental study using a rat model of malignant ascites].
Umemoto T; Saji S; Minatsu H; Kunii Y; Goshima H; Tachibana S; Takao H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jun; 23(6):1229-35. PubMed ID: 3230342
[No Abstract] [Full Text] [Related]
36. Neutrophil-mediated tumor cell destruction in cancer ascites. II. A OK-432 attracts killer neutrophils through activation of complement C5.
Fujimura T; Torisu M
Clin Immunol Immunopathol; 1987 May; 43(2):174-84. PubMed ID: 3105938
[TBL] [Abstract][Full Text] [Related]
37. [Treatment of malignant ascites. I. Clinical studies on intraperitoneal injection of a streptococcal preparation, OK-432 (author's transl)].
Katano M
Fukuoka Igaku Zasshi; 1981 Oct; 72(10):532-42. PubMed ID: 7327498
[No Abstract] [Full Text] [Related]
38. [Production of a cytotoxic factor in mouse peritoneal fluid by OK-432, a streptococcal preparation].
Yamamoto A; Nagamuta M; Usami H; Sugawara Y; Watanabe N; Niitsu Y; Urushizaki I
Gan To Kagaku Ryoho; 1986 May; 13(5):1905-10. PubMed ID: 3707150
[TBL] [Abstract][Full Text] [Related]
39. [Local immunotherapy with streptococcal preparation, OK-432 in superficial bladder tumors, and common antigens between OK-432 and the tumor].
Fujioka T; Shiraishi M; Tanji S; Koike H; Suzuki K; Kumagai K; Aoki H; Sakuma Y; Ohhori T; Kubo T
Hinyokika Kiyo; 1989 Feb; 35(2):253-7. PubMed ID: 2735236
[TBL] [Abstract][Full Text] [Related]
40. [Antitumor activity of neutrophils induced by a nonspecific immunopotentiator OK-432. II. Experimental study using human malignant ascites].
Umemoto T; Saji S; Oonishi A; Kunii Y; Goshima H; Tachibana S; Takao H; Tanemura H; Sakata K
Nihon Gan Chiryo Gakkai Shi; 1988 Jul; 23(7):1512-7. PubMed ID: 3183459
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
